Blue Ortho appears in FDA records as the applicant behind GPS Ankle, a Class II stereotaxic instrument under 21 CFR 882.4560 and product code OLO. The K262567 record lists a Meylan, France filing address, a decision date of October 26, 2026 and a substantially equivalent decision. Manufacturer documentation ties the device to total ankle arthroplasty navigation and to the Vantage Total Ankle System, with Blue Ortho SAS identified as developer and Advita Ortho, LLC as distributor. [1][3][2][4]

The K262567 filing and its scope

The FDA record for K262567 names Blue Ortho as applicant for GPS Ankle, received July 24, 2026 and decided October 26, 2026 as substantially equivalent. The record carries product code OLO, regulation number 882.4560, regulatory class II, a traditional clearance type and a summary statement. The advisory committee is listed as Neurology, with the review advisory committee listed as Orthopedic. [1]

An FDA letter addressed to Matthieu Coic, Quality and Regulatory Director at Blue Ortho, repeats the trade name GPS Ankle, the same regulation number and class, and the July 24, 2026 receipt date. The letter is part of the public correspondence for the same submission. [3]

What GPS Ankle is documented to do

Advita Ortho’s product page describes GPS Ankle as a navigation system for total ankle replacement, powered by Active Intelligence, with real-time navigation and surgical insights. The page lists real-time selection and testing of implant size, resection heights, and degrees of varus/valgus, rotation, slope and medial/lateral position. [2]

A product sheet describes GPS Ankle as compact and mobile, used within the sterile field with a touchscreen tablet, and states that intraoperative instrument guidance connects to the surgical plan in real time. The same sheet states that integrated CT visibility may reduce potential fluoroscopy time. [5]

The operative technique document covers the GPS Ankle application with the Vantage Total Ankle System and describes checking tibial cut position and orientation by attaching the G Tracker to the Cut Checker, with the tracker oriented toward the camera. [4]

Imaging inputs and company relationships

A CT scan protocol for Vantage Ankle PSI and Advita GPS Ankle specifies uncompressed DICOM files, slice spacing of 1.25 mm or smaller, pixel size of 0.8 mm or smaller, zero-degree tilt, named reconstruction algorithms and helical or axial scan modes. The protocol also shows anterior, lateral and mortise X-ray samples. [6]

Advita Ortho documentation states that GPS, Shoulder Planning App and Predict+ are developed by Blue Ortho SAS, an Advita Ortho subsidiary, and distributed by Advita Ortho, LLC, with products manufactured by Exactech, Inc. The product sheet repeats that GPS is manufactured by Blue Ortho SAS and distributed by Advita Ortho, LLC, and that Vantage Ankle is manufactured by Exactech. [2][5]

Earlier ankle navigation record

An earlier FDA letter dated November 16, 2023 addresses Blue Ortho for K232521, trade name ExactechGPS Total Ankle Application, under the same regulation number and class with product codes OLO and LLZ. The accompanying summary lists Blue Ortho in Meylan as submitter and Exactech, Inc. in Gainesville, Florida as US local agent, and references the patient’s preoperative CT scan. [8]